Indoco Remedies Limited Share Price and Company Fundamentals



Price
₹379
Change
2.600 (0.691%)
52 week
322.7 - 530.25

Last traded: Today at 4:17 AM

Indoco Remedies Limited manufactures and sells formulations and active pharmaceutical ingredients in India and internationally. The company offers respiratory products, such as Karvol Plus, Febrex Plus, and Tuspel; stomatologicals products that include Sensodent-K, Sensoform Toothpaste, Sensoform Gum Paint, Rexidin M, Rexidin SRS, RR Sensoform Dental, Snowdent, Kidodent, Rexidin Plus, and Dentogel; gastrointestinal products, such as Carmicide, Cyclopam, Cyclomeff, and Nosic; pain/analgesics products that include Lignox and T-lac; and ophthal/otologicals products, such as Renolen, Homide, Dexoren – S, Zincoren, Otorex, Mofloren-D, and Mofloren LP. It also provides vitamins/minerals/nutrients that include Methycal, Cital UTI, SM Fibro, Cal Aid, SM Fibro, MCBM DHA, and Apispur; urology products, such as Carmicide and Cital; Cloben G and Scabex for dermatology; ATM for anti-infectives; Hemsyl for blood related; MCBM 69 and D Chiro for gynecological; and Spear for anti-haemorrhoidal. In addition, the company provides analytical services, such as impurity profile, particle size analysis, heavy metal analysis, polymorphism and compatibility studies, extractables and leachables studies, lyophilization studies, reference and working standards, forced degradation studies, and chromatographic method development and validation services. Further, it offers services that include architectural design, lighting, mechanical and utility engineering, project and construction management, electrical, control system, piping, structural design, data transfer system, and process engineering. The company serves general practitioners, pediatricians, consultant physicians, dentists, cardiologists, diabetologists, endocrinologists, gynaecologists, and ophthalmologists. The company was formerly known as Indo Continental Trading Company. Indoco Remedies Limited was founded in 1945 and is based in Mumbai, India.

Key Metrics

PE ratio

21.88

PB ratio

3.74

Dividend yield

0.40%

Beta

0.57

Market cap

-

Enterprise value

-

Company profile

Industry / SectorDrug Manufacturers—Specialty & Generic / Healthcare
Full time employees6000
Websitehttps://www.indoco.com
Mailing addressIndoco House 166 CST Road Vidyanagari Marg Kalina Santacruz (East) Mumbai 400098 India
Phone / Fax91 22 6287 1000 / 91 22 6287 1050

Dividends

Dividend yield

0.40%

Dividend amount

₹1.50

Payout ratio

8.93%

5Y Avg. yield

0.38%

Indoco Remedies Limited paid ₹1.50 dividend and the ex-dividend date was 20 Sept 2021.The dividend payout ratio is 8.93%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.INDOCO dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.

INDOCO's forward dividend amount is ₹1.5 and the forward dividend yield is 0.40%. A forward dividend yield is the percentage of a company's current stock price that it expects to pay out as dividends over a certain time period, generally 12 months. Forward dividend yields are generally used in circumstances where the yield is predictable based on past instances. If not, trailing yields, which indicate the same value over the previous 12 months, are used.

Company Executives

As of Jul 2022, following are the company executives and directors listed on Indoco Remedies Limited.

NameTitleAgeTotal Pay
Mr. Suresh Govind KareExec. Chairman8234.84M
Mr. Sundeep Vasant BambolkarJoint MD & Exec. Director6127.81M
Ms. Aditi Milind PanandikarMD & Exec. Director5130M
Mr. Jayshankar MenonCompany Sec., Compliance Officer & Assistant VP of Legal563.31M
Mr. Pramod GhorpadeChief Financial Officer
Mr. A. S. RegePres of Operations
Mr. Bandari Rajendra KumarSr. VP of Marketing
Mr. Sunil D. JoshiPres of Fin.
Dr. Kavita InamdarPres of R&D (Formulations)54
Mr. Vilas V. NagarePres of Corp. Affairs and M&A

Profitability and management effectiveness

Profit margin

10.05%

Operating margin

16.27%

Return on assets

11.19%

Return on equity

18.50%

Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.

The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.

Valuation and Trading Info

The market capitalization of Indoco Remedies Limited is and its enterprise value is .

The INDOCO's stocks Beta value is 0.57 making it 43% less volatile compared to NSE market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.

Indoco Remedies Limited (NSE:INDOCO) Frequently Asked Questions

1. What is Indoco Remedies Limited's Stock Symbol?

Indoco Remedies Limited trades on NSE under the ticker symbol "INDOCO".

2. What is Indoco Remedies Limited's stock price today?

One share of INDOCO stock can currently be purchased for approximately ₹379.

3. How can I contact Indoco Remedies Limited?

Indoco Remedies Limited's mailing address is Indoco House 166 CST Road Vidyanagari Marg Kalina Santacruz (East) Mumbai 400098 India. The company can be reached via phone at 91 22 6287 1000.

4. What is Indoco Remedies Limited's official website?

The official website of Indoco Remedies Limited is https://www.indoco.com.